• Charles’ Take: Why Tech Stocks and Smart Bets Are Ready to Booming
    Jul 11 2026
    Charles is joined by Valtrion CEO Rob Luna to discuss how big tech companies like Meta are spending money now to make massive profits later, why popular tech tools like Micron, CrowdStrike, and Snowflake are still great long-term buys, and how to find hidden gems in small healthcare stocks. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    6 mins
  • Charles’ Take: Why Investors are Misreading the Sell-Off in Korean and American Markets
    Jul 10 2026
    Charles is joined by Nicholas Megaw, Principal of World Trade Securities, to discuss why investors aren't actually fleeing AI, the risk of retail leverage triggers in the Kospi, and why the current pullback in foundational names like Arm provides a massive second-chance opportunity. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    6 mins
  • Charles’ Take: Is Wall Street's Favorite Formula Broken?
    Jul 9 2026
    Charles is joined by Victoria Fernandez, Chief Market Strategist at Crossmark Global Investments, to discuss why even the biggest Wall Street fund managers are struggling right now, why a legendary investor is dumping stocks to chase short-term trends, and whether software giants like Fortinet and Adobe are still safe bets for your money. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    8 mins
  • Charles' Take: Navigating the Tech Sell-Off
    Jul 8 2026
    Charles is joined by Spire Investments Founder and CIO Ivana Delevska to discuss how algorithmic selling creates buying opportunities in fundamentally strong tech names, why a massive expansion in CPU and memory capacity positions semiconductor equipment and optical sectors for long-term growth, and why resilient business models make software and cybersecurity attractive plays. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    8 mins
  • Charles’ Take: The Fed's New Playbook
    Jul 7 2026
    Charles is joined by Hennessy & Warsh Asset Management CIO Kevin Maughan to discuss why the new Fed Chair will rewrite inflation rules, how a slowing economy could pause rate hikes, and which AI infrastructure and biotech stocks to buy now. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    8 mins
  • Charles’ Take: Buying the Dip from Mushrooms to Microchips
    Jun 24 2026
    Charles is joined by Hilary Kramer, President of Greetech Research, to discuss why this bull market still has room to run, why Micron’s recent stock drop is a massive buying opportunity driven by AI data center demand, a smart short-term trade to play South Korea, and how to spot explosive upside in biotech "mushroom" stocks. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    6 mins
  • Charles' Take: Why This Secular Bull Market Still Has Legs
    Jun 23 2026
    Charles Payne is joined by Hennion & Walsh President and CIO Kevin Mahn to discuss the Magnificent Seven lagging as the broader market rallies, why massive growth makes Micron and the "Air 7" attractive AI plays, and how Alan Greenspan's passing highlights the Fed's need to prioritize Main Street over Wall Street. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    9 mins
  • Charles' Take: ODE To American Greatness
    Jun 19 2026
    Charles Payne reflects on the upcoming Juneteenth holiday by connecting the end of the Civil War to a 200-year trajectory of American freedom, innovation, and prosperity originally set in motion by the founding fathers. He emphasizes that the current stock market highs and technological breakthroughs, such as AI and robotics, are direct products of a constitutional foundation designed to foster long-term economic growth and human potential. Learn more about your ad choices. Visit podcastchoices.com/adchoices
    Show More Show Less
    5 mins